# Comparison of Available Standard Pulse Field Ablation Methods for Pulmonary Vein Isolation for Treatment of Atrial Fibrillation

Study · id `cardio:ct-nct07456540` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07456540](<https://clinicaltrials.gov/study/NCT07456540>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07456540

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1125 participants.

## Technical summary

Registry record NCT07456540. Randomized; double masking; primary purpose treatment. Start 2026-02-15 (anticipated); primary completion 2030-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1125 participants (planned count; ClinicalTrials.gov record NCT07456540, source copy `cardio:ctgov-nct07456540-2026-03-06`, retrieved 2026-10-26)
- Planned start: 2026-02-15 (anticipated) (ClinicalTrials.gov record NCT07456540, source copy `cardio:ctgov-nct07456540-2026-03-06`, retrieved 2026-10-26)
- Primary completion: 2030-04-30 (anticipated) (ClinicalTrials.gov record NCT07456540, source copy `cardio:ctgov-nct07456540-2026-03-06`, retrieved 2026-10-26)
- Completion: 2030-04-30 (anticipated) (ClinicalTrials.gov record NCT07456540, source copy `cardio:ctgov-nct07456540-2026-03-06`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT07456540, source copy `cardio:ctgov-nct07456540-2026-03-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07456540-2026-03-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Available Standard Pulse Field Ablation Methods for Pulmonary Vein Isolation for Treatment of Atrial Fibrillation
- Acronym: PVI-MODE
- Condition: Atrial Fibrillation
- Intervention (Device): Pulse field ablation Systems
- Lead sponsor: Copenhagen University Hospital, Rigshospitalet
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Copenhagen University Hospital, Rigshospitalet (`cardio:org-copenhagen-university-hospital-rigshospitalet`)

## Provenance

Content hash: d2da750cda6fb881e3ae793f50620f66c6c6fe5e63acb678cc3bbfdf44c4ff8c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
